Related Experiment Videos

Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis

R Hokari1, S Kato, K Matsuzaki

  • 1Second Department of Internal Medicine, National Defense Medical College, Saitama, Japan.

Abstract

Insights

Inducible nitric oxide synthase (iNOS) contributes to chronic colitis by causing tissue damage. Mice lacking iNOS showed significantly reduced inflammation and cell infiltration in experimental colitis, highlighting iNOS

Area of Science:

  • Gastroenterology and Immunology
  • Inflammatory Bowel Disease Research

Background:

  • The role of nitric oxide (NO) in colitis pathogenesis is debated, with potential toxic and protective effects attributed to its overproduction by inducible nitric oxide synthase (iNOS).
  • Understanding iNOS' specific contribution is crucial for developing targeted therapies for chronic inflammatory conditions of the colon.

Purpose of the Study:

  • To investigate the role of iNOS in the development of experimental chronic colitis.
  • To assess the impact of iNOS deficiency on colonic inflammation, leukocyte infiltration, and cell adhesion molecule expression.

Main Methods:

  • Experimental chronic colitis was induced in mice using multiple cycles of dextran sodium sulfate (DSS) administration.
  • iNOS-deficient mice and wild-type controls were used to compare disease severity.
  • Colonic inflammation, leukocyte infiltration, iNOS expression, nitrotyrosine levels, and cell adhesion molecule expression were evaluated using histological and immunohistochemical analyses.

Main Results:

  • DSS treatment induced moderate colitis with significant leukocyte infiltration and iNOS expression in wild-type mice.
  • iNOS-deficient mice exhibited significantly diminished tissue damage, reduced leukocyte infiltration, and lower expression of mucosal adressin cell adhesion molecule-1.
  • No iNOS or nitrotyrosine staining was detected in iNOS-deficient mice, confirming the absence of iNOS activity.

Conclusions:

  • The induction of iNOS plays a critical role as a toxic effector molecule in the pathogenesis of chronic colonic inflammation.
  • Targeting iNOS may represent a viable therapeutic strategy for managing chronic colitis.

Related Concept Videos